A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
As the investigation into Khalid Masood continues, former acquaintances tell of violent incidents in the murderer's past.
Local authorities say the current system of Traffic Regulation Orders are time-consuming, expensive and bureaucratic.
A recording of the actor's apology to air traffic control has been released after he mistakenly landed his plane on a taxiway last month.